Source: FierceBiotech

Creyon: Creyon joins wave of AI biotechs with $40M to create 'on demand' RNA-based medicines

Creyon joins wave of AI biotechs with $40M to create 'on demand' RNA-based medicines klahucik Tue, 03/08/2022 - 08:59

Read full article »

Creyon's Competitors | Creyon's News | Creyon's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

President & CEO

Christopher Hart

CEO Approval Rating

- -/100

Creyon is a California-based preclinical stage company that researches and commercializes oligonucleotide medicines for the treatment of respiratory diseases.